Related Experiment Videos
An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis
G V McDonnell1, C W Kirk, S A Hawkins
1Northern Ireland Neurology Service, Royal Victoria Hospital, Northern Ireland, Belfast, UK.
Abstract:
Differential expression of interleukins may influence susceptibility to inflammatory diseases such as MS. IL-1a production is increased in MS patients during acute relapse, IL-2 receptor (IL-2R) secretion correlates with disease activity in several inflammatory disorders and is variable in MS. Both IL-4 and IL-10 expression vary significantly with relapse/remission in MS and IL-9 is postulated to inhibit steroid-induced apoptosis. To examine the influence of interleukin (IL) genes on MS susceptibility and clinical course, gene association studies using separate polymorphic microsatellite markers for il-1 alpha, il-2, il-2r beta, il-4 il-9 and il-10 were performed, incorporating 150-177 relapsing-remitting or secondary progressive MS (RR/SPMS) patients, 100-110 primary progressive (PPMS) patients and 152-210 controls. No significant differences existed in allele frequencies between either MS group and controls for any of the interleukin microsatellite markers studied, nor were statistically significant differences observed in PPMS vs. RR/SPMS for any marker. These data indicate that the IL-1 alpha, IL-2, IL-2R beta, IL-4, IL-9 and IL-10 genes are unlikely to be susceptibility loci for MS in this population.
Insights
Interleukin gene variations do not appear to influence susceptibility to multiple sclerosis (MS). This study found no significant association between specific interleukin gene markers and MS risk or clinical course in the studied population.
Area of Science:
- Immunogenetics
- Neuroimmunology
- Genetics of Inflammatory Diseases
Background:
- Interleukins (ILs) are key immune mediators implicated in inflammatory diseases.
- Differential IL expression, including IL-1a, IL-2 receptor (IL-2R), IL-4, IL-10, and IL-9, has been observed in multiple sclerosis (MS) and other inflammatory conditions.
- The specific role of these IL genes in MS susceptibility and disease progression remains to be fully elucidated.
Purpose of the Study:
- To investigate the association between genetic variations in interleukin genes and susceptibility to multiple sclerosis (MS).
- To examine the influence of these interleukin gene polymorphisms on the clinical course of MS, including different disease subtypes.
- To determine if specific interleukin genes act as susceptibility loci for MS in the studied population.
Main Methods:
- Gene association studies were conducted using polymorphic microsatellite markers for IL-1 alpha, IL-2, IL-2R beta, IL-4, IL-9, and IL-10.
- The study included patients with relapsing-remitting/secondary progressive MS (RR/SPMS), primary progressive MS (PPMS), and healthy controls.
- Allele frequencies of the selected interleukin markers were compared between MS patient groups and controls, and between different MS subtypes.
Main Results:
- No statistically significant differences were found in the allele frequencies of the studied interleukin microsatellite markers between MS patient groups (RR/SPMS, PPMS) and controls.
- No significant differences in allele frequencies were observed when comparing the PPMS group directly with the RR/SPMS group for any of the interleukin markers.
- These findings suggest a lack of association between the investigated IL genes and MS susceptibility or disease course.
Conclusions:
- The IL-1 alpha, IL-2, IL-2R beta, IL-4, IL-9, and IL-10 genes are unlikely to represent susceptibility loci for multiple sclerosis in this population.
- Genetic variations in these specific interleukin genes do not appear to play a significant role in determining MS risk or influencing its clinical presentation.
- Further research may be needed to explore other genetic factors or environmental influences contributing to MS pathogenesis.